Cargando…
Review of the Novel Echinocandin Antifungal Rezafungin: Animal Studies and Clinical Data
Rezafungin is a novel echinocandin drug being developed as a first-line option for treatment and prevention of invasive fungal infections. As a result of a structural modification in its parent molecule anidulafungin, rezafungin has acquired unique chemical stability conferring prolonged pharmacokin...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712954/ https://www.ncbi.nlm.nih.gov/pubmed/32998224 http://dx.doi.org/10.3390/jof6040192 |